Global Technologies Ltd. (GTLL)
OTC PINK OTC PINK Primary 
Zeta Global: Dirt Cheap, Blowout Q3 Earnings
Zeta Global (ZETA) is rated a Strong Buy, with my DCF model indicating the stock is substantially undervalued and offers 61% upside potential. ZETA's Q3 earnings were stellar, showing 26% YoY revenue growth, robust operating leverage, and impressive gains in cash from operations and adjusted EBITDA. Management's growth initiatives, including the Athena AI agent and Marigold acquisition, support continued aggressive revenue and profitability growth into FY2026.
Zeta Global's AI Engine Is Just Warming Up
Revenue rose 26% year over year to $337 million, or 28% excluding political and LiveIntent revenue, showcasing accelerating AI-driven growth. Direct platform revenue reached 75% of total sales, up from 70% last year, reflecting higher-margin enterprise adoption of ZMP. 2026 guidance targets $1.54 billion in revenue (+21%), $354 million in EBITDA (23% margin), and $209 million in free cash flow.
Global Payments Says New Point-of-Sale Software is Resonating with Merchants
Global Payments' new point-of-sale software, Genius, has been resonating with merchants since the launch of its configurations for restaurants and retail in the second quarter, executives said Tuesday (Nov. 4) during the company's third quarter earnings call.
Global Payments Q3 Earnings Beat on Merchant Solutions Strength
GPN tops Q3 earnings and revenue estimates as Merchant and Issuer Solutions drive growth and margins expand.
Apollo Global Q3 Earnings Beat Estimates, AUM Increase Y/Y
APO's Q3 earnings and revenues top estimates as rising AUM and the Bridge acquisition fuel strong growth despite higher expenses.
From the AI Power Bill to Impact of Global Currency Shifts
Every month, TMX VettaFi publishes hundreds of articles across our ETF-focused websites. Reviewing the pieces that capture our readers' attention provides a clear picture of prevailing advisor and investor sentiment.
Remitly Global Set to Report Q3 Earnings: What's in Store?
RELY aims for strong third-quarter 2025 growth, driven by rising send volumes, digital momentum and new U.S. expansion.
Zeta Global Set to Report Q3 Earnings: What's in the Offing?
ZETA's AI-driven platform and new tools like Zeta Answers and OneZeta are expected to fuel strong third-quarter 2025 growth.
Bristol-Myers Squibb: Increased Global Breyanzi Sales Isn't Only Hematological Product Growth
Bristol-Myers Squibb (BMY) remains a "Strong Buy" rating, driven by robust growth in its hematology and cardiovascular portfolios, especially Breyanzi and Camzyos. Breyanzi and Reblozyl achieved impressive year-over-year revenue growth, each generating over >$1 billion and >$2 billion in annual sales, respectively. The $1.5 billion acquisition of Orbital Therapeutics positions BMY to advance in vivo CAR-T therapies for autoimmune disorders, depleting autoreactive B-cells and resetting the immune system.
Oakmark Global Strategy Q3 2025 Portfolio Positioning
Adidas (ADDYY) is an iconic global sportswear brand specializing in athletic footwear, apparel and equipment. Hexagon (HXGBF) provides advanced sensor and software solutions that help companies measure, analyze, and act on the physical world. Dassault Systèmes (DASTY) is a French software company at the forefront of virtual twin technology, enabling customers to simulate the behavior of real-world products and systems in a digital environment.
Oakmark Global Strategy Q3 2025 Contributors And Detractors
Oakmark Global Strategy portfolio's return was 4.70% (net) for the reporting period vs. MSCI World Index that returned 7.27% for the same period. Kering (PPRUF), Alibaba Group (BABA) and Alphabet Cl A (GOOG) were the contributors. Charter Communications Cl A (CHTR), Centene (CNC) and Keurig Dr Pepper (KDP) were the detractors.
U.S. Futures, Global Markets Start New Month Mostly Higher; Oil Rises After OPEC+ Meeting
Futures for the S&P 500 were up with focus on earnings. About a quarter of companies on the index are due to report this week.
